Literature DB >> 20371487

S-nitrosylation from GSNOR deficiency impairs DNA repair and promotes hepatocarcinogenesis.

Wei Wei1, Bin Li, Martha A Hanes, Sanjay Kakar, Xin Chen, Limin Liu.   

Abstract

Human hepatocellular carcinoma (HCC) is associated with elevated expression of inducible nitric oxide synthase (iNOS), but the role of nitric oxide in the pathogenesis of HCC remains unknown. We found that the abundance and activity of S-nitrosoglutathione reductase (GSNOR), a protein critical for control of protein S-nitrosylation, were significantly decreased in approximately 50% of patients with HCC. GSNOR-deficient mice were very susceptible to spontaneous and carcinogen-induced HCC. During inflammatory responses, the livers of GSNOR-deficient mice exhibited substantial S-nitrosylation and proteasomal degradation of the key DNA repair protein O(6)-alkylguanine-DNA alkyltransferase. As a result, repair of carcinogenic O(6)-alkylguanines in GSNOR-deficient mice was significantly impaired. Predisposition to HCC, S-nitrosylation and depletion of alkylguanine-DNA alkyltransferase, and accumulation of O(6)-alkylguanines were all abolished in mice deficient in both GSNOR and iNOS. Thus, our data suggest that GSNOR deficiency, through dysregulated S-nitrosylation, may promote HCC, possibly by inactivating a DNA repair system.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20371487      PMCID: PMC3085984          DOI: 10.1126/scitranslmed.3000328

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  58 in total

1.  Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma.

Authors:  S H Yeh; P J Chen; W Y Shau; Y W Chen; P H Lee; J T Chen; D S Chen
Journal:  Gastroenterology       Date:  2001-09       Impact factor: 22.682

Review 2.  Proteasome inhibitors: from research tools to drug candidates.

Authors:  A F Kisselev; A L Goldberg
Journal:  Chem Biol       Date:  2001-08

Review 3.  NO: an inhibitor of cell death.

Authors:  L Liu; J S Stamler
Journal:  Cell Death Differ       Date:  1999-10       Impact factor: 15.828

4.  Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases.

Authors:  M A Rahman; D K Dhar; E Yamaguchi; S Maruyama; T Sato; H Hayashi; T Ono; A Yamanoi; H Kohno; N Nagasue
Journal:  Clin Cancer Res       Date:  2001-05       Impact factor: 12.531

5.  Active and alkylated human AGT structures: a novel zinc site, inhibitor and extrahelical base binding.

Authors:  D S Daniels; C D Mol; A S Arvai; S Kanugula; A E Pegg; J A Tainer
Journal:  EMBO J       Date:  2000-04-03       Impact factor: 11.598

6.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

7.  Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: oxyradical overload diseases.

Authors:  S P Hussain; K Raja; P A Amstad; M Sawyer; L J Trudel; G N Wogan; L J Hofseth; P G Shields; T R Billiar; C Trautwein; T Hohler; P R Galle; D H Phillips; R Markin; A J Marrogi; C C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

8.  A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans.

Authors:  L Liu; A Hausladen; M Zeng; L Que; J Heitman; J S Stamler
Journal:  Nature       Date:  2001-03-22       Impact factor: 49.962

9.  Protein S-nitrosylation: a physiological signal for neuronal nitric oxide.

Authors:  S R Jaffrey; H Erdjument-Bromage; C D Ferris; P Tempst; S H Snyder
Journal:  Nat Cell Biol       Date:  2001-02       Impact factor: 28.824

10.  Spontaneous hepatocellular carcinoma is reduced in transgenic mice overexpressing human O6- methylguanine-DNA methyltransferase.

Authors:  Z Q Zhou; D Manguino; K Kewitt; G W Intano; C A McMahan; D C Herbert; M Hanes; R Reddick; Y Ikeno; C A Walter
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

View more
  69 in total

1.  Proteomic analysis of the role of S-nitrosoglutathione reductase in lipopolysaccharide-challenged mice.

Authors:  Kentaro Ozawa; Hiroki Tsumoto; Wei Wei; Chi-Hui Tang; Akira T Komatsubara; Hiroto Kawafune; Kazuharu Shimizu; Limin Liu; Gozoh Tsujimoto
Journal:  Proteomics       Date:  2012-06       Impact factor: 3.984

2.  S-nitrosoglutathione reductase deficiency-induced S-nitrosylation results in neuromuscular dysfunction.

Authors:  Costanza Montagna; Giuseppina Di Giacomo; Salvatore Rizza; Simone Cardaci; Elisabetta Ferraro; Paolo Grumati; Daniela De Zio; Emiliano Maiani; Carolina Muscoli; Filomena Lauro; Sara Ilari; Sergio Bernardini; Stefano Cannata; Cesare Gargioli; Maria R Ciriolo; Francesco Cecconi; Paolo Bonaldo; Giuseppe Filomeni
Journal:  Antioxid Redox Signal       Date:  2014-05-13       Impact factor: 8.401

Review 3.  S-Nitrosothiol biology and therapeutic potential in metabolic disease.

Authors:  Christopher G Kevil; Rakesh P Patel
Journal:  Curr Opin Investig Drugs       Date:  2010-10

4.  Comparative protein profiling of B16 mouse melanoma cells susceptible and non-susceptible to alphavirus infection: Effect of the tumor microenvironment.

Authors:  Jelena Vasilevska; Gustavo Antonio De Souza; Maria Stensland; Dace Skrastina; Dmitry Zhulenvovs; Raimonds Paplausks; Baiba Kurena; Tatjana Kozlovska; Anna Zajakina
Journal:  Cancer Biol Ther       Date:  2016-09-16       Impact factor: 4.742

5.  S-nitrosoglutathione reductase in human lung cancer.

Authors:  Nadzeya V Marozkina; Christina Wei; Sean Yemen; Horst Wallrabe; Alykhan S Nagji; Lei Liu; Tatiana Morozkina; David R Jones; Benjamin Gaston
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01       Impact factor: 6.914

6.  Membrane transfer of S-nitrosothiols.

Authors:  Akio Matsumoto; Andrew J Gow
Journal:  Nitric Oxide       Date:  2011-03-04       Impact factor: 4.427

7.  Nitric oxide-regulated proteolysis of human CYP2B6 via the ubiquitin-proteasome system.

Authors:  Choon-Myung Lee; Shweta Tripathi; Edward T Morgan
Journal:  Free Radic Biol Med       Date:  2017-04-17       Impact factor: 7.376

Review 8.  Enzymatic mechanisms regulating protein S-nitrosylation: implications in health and disease.

Authors:  Puneet Anand; Jonathan S Stamler
Journal:  J Mol Med (Berl)       Date:  2012-02-24       Impact factor: 4.599

Review 9.  Cysteine-mediated redox signaling: chemistry, biology, and tools for discovery.

Authors:  Candice E Paulsen; Kate S Carroll
Journal:  Chem Rev       Date:  2013-03-20       Impact factor: 60.622

10.  Hepatocarcinogenesis driven by GSNOR deficiency is prevented by iNOS inhibition.

Authors:  Chi-Hui Tang; Wei Wei; Martha A Hanes; Limin Liu
Journal:  Cancer Res       Date:  2013-02-25       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.